ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAUT Nautilus Biotechnology Inc

2.49
0.13 (5.51%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 30,030
Bid Price 2.47
Ask Price 2.92
News -
Day High 2.52

Low
2.16

52 Week Range

High
4.65

Day Low 2.34
Share Name Share Symbol Market Stock Type
Nautilus Biotechnology Inc NAUT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.13 5.51% 2.49 15:17:30
Open Price Low Price High Price Close Price Previous Close
2.42 2.34 2.52 2.49 2.36
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
414 30,030 US$ 2.45 US$ 73,586 - 2.16 - 4.65
Last Trade Type Quantity Price Currency
16:48:54 10 US$ 2.46 USD

Nautilus Biotechnology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
311.49M 125.10M - 0 -63.68M -0.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nautilus Biotechnology News

Date Time Source News Article
4/11/202407:00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024..
3/06/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
3/06/202415:39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
3/05/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202407:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal..
2/28/202406:26Edgar (US Regulatory)Form 8-K - Current report
2/28/202406:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
2/28/202406:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NAUT Message Board. Create One! See More Posts on NAUT Message Board See More Message Board Posts

Historical NAUT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.312.602.312.4147,8330.187.79%
1 Month2.903.072.312.5562,901-0.41-14.14%
3 Months2.843.102.312.6679,695-0.35-12.32%
6 Months2.473.45472.302.8286,1840.020.81%
1 Year2.444.652.163.0491,0290.052.05%
3 Years11.4912.381.504.96253,772-9.00-78.33%
5 Years11.4912.381.504.96253,772-9.00-78.33%

Nautilus Biotechnology Description

With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome.

Your Recent History

Delayed Upgrade Clock